vVARDIS offers innovative biomimetic dental products under the CURODONT brand, designed to treat early-stage decay and promote tooth enamel remineralization.
vVARDIS has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Zug, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-28 | Other | — |
| Apollo-managed funds |
| View deal → |
